Kunle Odunsi named SITC board member

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Kunle Odunsi, deputy director of Roswell Park Comprehensive Cancer Center, was named an at-large director of the Society for Immunotherapy of Cancer Board of Directors.

The organization’s members voted for Odunsi during their election in May. He will begin his three-year term in January 2021.

Odunsi is also the Robert, Anne & Lew Wallace Endowed Chair in Cancer Immunotherapy, executive director of the Center for Immunotherapy and M. Steven Piver Endowed Professor and chair of the Department of Gynecologic Oncology at Roswell Park.

A fellow of both the Royal College of Obstetricians and Gynaecologists in the United Kingdom and the American College of Obstetricians and Gynecologists, he holds lifetime membership in the National Academy of Medicine.

Table of Contents

YOU MAY BE INTERESTED IN

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login